{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:23:01Z","timestamp":1761319381453,"version":"build-2065373602"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"DOI":"10.7759\/cureus.95330","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:17:54Z","timestamp":1761319074000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Vasovagal Syncope in a Patient Receiving Pembrolizumab for Postoperative Pulmonary Metastases of Laryngeal Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Rentaro","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Tokashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoaki","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.001","article-title":"Management of toxicities of immune checkpoint inhibitors","volume":"44","author":"Spain L","year":"2016","unstructured":"Spain L, Diem S, Larkin J. Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev. 2016, 44:51-60. 10.1016\/j.ctrv.2016.02.001","journal-title":"Cancer Treat Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.01.008","article-title":"The expanding role of immunotherapy","volume":"54","author":"Martin-Liberal J","year":"2017","unstructured":"Martin-Liberal J, de Olza MO, Hierro C, Gros A, Rodon J, Tabernero J. The expanding role of immunotherapy. Cancer Treat Rev. 2017, 54:74-86. 10.1016\/j.ctrv.2017.01.008","journal-title":"Cancer Treat Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.02.024","article-title":"Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy","volume":"60","author":"Zimmer L","year":"2016","unstructured":"Zimmer L, Goldinger SM, Hofmann L, et al.. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer. 2016, 60:210-25. 10.1016\/j.ejca.2016.02.024","journal-title":"Eur J Cancer"},{"key":"ref4","article-title":"Vasovagal episode","author":"Jeanmonod R","year":"2023","unstructured":"Jeanmonod R, Sahni D, Silberman M. Vasovagal episode. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref5","article-title":"Syncope in older adults","volume":"13","author":"Goyal P","year":"2016","unstructured":"Goyal P, Maurer MS. Syncope in older adults. J Geriatr Cardiol. 2016, 13:380-6.","journal-title":"J Geriatr Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1340373","article-title":"Immune checkpoint inhibitors associated cardiovascular immune-related adverse events","volume":"15","author":"Jo W","year":"2024","unstructured":"Jo W, Won T, Daoud A, \u010cih\u00e1kov\u00e1 D. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events. Front Immunol. 2024, 15:10.3389\/fimmu.2024.1340373","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032240","article-title":"Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: a case report and literature review","volume":"101","author":"Gao L","year":"2022","unstructured":"Gao L, Li X, Guo Z, Tang L, Peng J, Liu B. Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: a case report and literature review. Medicine (Baltimore). 2022, 101:10.1097\/MD.0000000000032240","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000526561","article-title":"A case of nonsmall-cell lung cancer with anaphylaxis after 41 courses of pembrolizumab along with adrenal insufficiency as an immune-related adverse event","volume":"15","author":"Nakamura T","year":"2022","unstructured":"Nakamura T, Imai R, Nishimura N. A case of nonsmall-cell lung cancer with anaphylaxis after 41 courses of pembrolizumab along with adrenal insufficiency as an immune-related adverse event. Case Rep Oncol. 2022, 15:804-8. 10.1159\/000526561","journal-title":"Case Rep Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp298","article-title":"Guidelines for the diagnosis and management of syncope (version 2009): the task force for the diagnosis and management of syncope of the European Society of Cardiology (ESC)","volume":"30","author":"Moya A","year":"2009","unstructured":"Moya A, Sutton R, Ammirati F, et al.. Guidelines for the diagnosis and management of syncope (version 2009): the task force for the diagnosis and management of syncope of the European Society of Cardiology (ESC). Eur Heart J. 2009, 30:2631-71. 10.1093\/eurheartj\/ehp298","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/lary.1983.93.10.1290","article-title":"Carotid sinus hypersensitivity: a cause of syncope in patients with tumors of the head and neck","volume":"93","author":"Muntz HR","year":"1983","unstructured":"Muntz HR, Smith PG. Carotid sinus hypersensitivity: a cause of syncope in patients with tumors of the head and neck. Laryngoscope. 1983, 93:1290-3. 10.1002\/lary.1983.93.10.1290","journal-title":"Laryngoscope"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz038","article-title":"Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma","volume":"49","author":"Hatano T","year":"2019","unstructured":"Hatano T, Matsu-Ura T, Mori KI, Inaba H, Endo K, Tamari M, Egawa S. Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma. Jpn J Clin Oncol. 2019, 49:473-6. 10.1093\/jjco\/hyz038","journal-title":"Jpn J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102904","article-title":"Management of vasovagal syncope","volume":"236","author":"Ballantyne BA","year":"2021","unstructured":"Ballantyne BA, Letourneau-Shesaf S, Raj SR. Management of vasovagal syncope. Auton Neurosci. 2021, 236:10.1016\/j.autneu.2021.102904","journal-title":"Auton Neurosci"},{"key":"ref13","article-title":"Vasovagal syncope: diagnosis and management. [Article in French]","volume":"10","author":"Etemadi AQ","year":"2014","unstructured":"Etemadi AQ, Sunthorn H. Vasovagal syncope: diagnosis and management. [Article in French]. Rev Med Suisse. 2014, 10:1179-82.","journal-title":"Rev Med Suisse"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab323","article-title":"Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis","volume":"24","author":"Lei LY","year":"2022","unstructured":"Lei LY, Raj SR, Sheldon RS. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. Europace. 2022, 24:1171-8. 10.1093\/europace\/euab323","journal-title":"Europace"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2022.102998","article-title":"Pacing for vasovagal syncope: tips for use in practice","volume":"241","author":"Morillo CA","year":"2022","unstructured":"Morillo CA, Brignole M. Pacing for vasovagal syncope: tips for use in practice. Auton Neurosci. 2022, 241:10.1016\/j.autneu.2022.102998","journal-title":"Auton Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.joa.2014.04.009","article-title":"Role of permanent cardiac pacing for vasovagal syncope","volume":"30","author":"Sumiyoshi M","year":"2014","unstructured":"Sumiyoshi M. Role of permanent cardiac pacing for vasovagal syncope. J Arrhythm. 2014, 30:417-20. 10.1016\/j.joa.2014.04.009","journal-title":"J Arrhythm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00549-x","article-title":"The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope","volume":"33","author":"Connolly SJ","year":"1999","unstructured":"Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999, 33:16-20. 10.1016\/s0735-1097(98)00549-x","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401344-recurrent-vasovagal-syncope-in-a-patient-receiving-pembrolizumab-for-postoperative-pulmonary-metastases-of-laryngeal-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:17:55Z","timestamp":1761319075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401344-recurrent-vasovagal-syncope-in-a-patient-receiving-pembrolizumab-for-postoperative-pulmonary-metastases-of-laryngeal-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.95330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}